we keep you informed with the latest breakthroughs, updates, and stories from Cercare Medical. Dive into our articles to discover how we're pushing the boundaries of perfusion imaging, learn about our recent projects, and hear from the experts leading the way. Stay connected with the innovations and insights shaping the future of medical imaging.
PRESS RELEASE Cercare Medical Selected for Nationwide Hospital Rollout in Norway Advanced Perfusion Imaging Software to Support Stroke and Oncology Diagnostics in Every Public Hospital. AARHUS, DENMARK, 23 June 2025: Cercare Medical is proud to announce its successful selection in the Norwegian National Tender for advanced imaging software. This award secures Cercare Medical’s installation across every […]
Cercare Medical Secures Additional Regulatory Clearance in South Korea Milestone approval and new partnership reinforce Cercare Medical’s strategic expansion across key Asian markets. AARHUS, DENMARK, 6 June 2025: Cercare Medical, a leader in advanced neuroimaging software, is pleased to announce it has received additional regulatory clearance in South Korea for its Cercare Medical Neurosuite with […]
PRESS RELEASE Cercare Medical Releases Version 17 of Neurosuite: Advancing Precision and Efficiency in Neuroimaging Latest update includes new, improved tools for more precise tumor assessment and stroke care. AARHUS, DENMARK, 4 June 2025: Cercare Medical, a leader in advanced neuroimaging software, is proud to announce the launch of CERCARE MEDICAL NEUROSUITE (CMN) Version 17. […]
PRESS RELEASE Cercare Medical Secures €7.4 Million in New Funding Round to Accelerate Growth in Key Markets Expansion Targets Leading Oncology and Stroke Clinics in the United States and Europe. AARHUS, DENMARK, 18 February 2025: Cercare Medical, a leader in perfusion software for stroke and neurodegenerative diseases since 2013, announced today that it has raised €7.4 […]
PRESS RELEASE Cercare Medical Secures FDA Clearance for CT Perfusion Imaging Software Milestone Achievement Expands Availability of Advanced Perfusion Imaging in Stroke Care. AARHUS, DENMARK, 12 Dec 2024: Cercare Medical is proud to announce FDA clearance for its CT perfusion imaging software, a significant milestone that complements the existing clearance for MRI perfusion imaging. This achievement underscores […]
PRESS RELEASE Groundbreaking Study Highlights Cercare Medical’s Role in Stroke Treatment Innovations Lyon Team's Study, Led by Dr. Bani-Sadr, Demonstrates How Advanced Biomarkers are Transforming Stroke Care. AARHUS, DENMARK, 27 Nov 2024: Cercare Medical proudly announces that a new study led by Dr. Alexandre Bani-Sadr and his team in Lyon, published on the front page of […]
Stroke ManagementM1 occlusionOEF increase Oncology Glioblastoma tumor recurrenceOEF increase Have you ever heard about Oxygen Extraction Fraction (OEF)? It’s an important biomarker in Cercare Medical Neurosuite software that ensures high-quality perfusion maps. In the world of advanced diagnostic imaging, the measurement of OEF is emerging as a critical indicator in diverse clinical settings, including stroke […]
Cercare Medical News: Revolutionizing Stroke Care: Cercare Medical Debuts CMN Version 14 Aarhus, Denmark - Embrace the future of stroke diagnosis with the launch of Cercare Medical Neurosuite (CMN) Version 14. This landmark release heralds a new era in precision neuroimaging, bringing forth groundbreaking features that promise to transform stroke management and patient care. René […]
Cercare Medical News: Celebrating Innovative Collaboration with Fondation Rothschild Hospital Cercare Medical is thrilled to announce a groundbreaking collaboration with the esteemed Fondation Rothschild Hospital. Our pioneering medical imaging software has been seamlessly integrated, marking a monumental stride in our mission to revolutionize medical diagnostics and elevate patient care on a global scale. Cercare Medical […]
Sign up for the upcoming Perfusion & Metabolic Imaging Community (PMIC)
Imaging
MTT
SVD model
MTT
Vascular Model
T2 FLAIR
follow-up image
Perfusion maps of a stroke patient show a large difference in lesion appearance compared to the SVD technique, where the VM appears in better correspondence with the T2 FLAIR follow-up.
MTT
SVD model
MTT
Vascular Model
T2 FLAIR
follow-up image
The modest degree of tissue involvement is consistent with the moderate neurologic deficits, National Institutes of Health Stroke Scale (NIHSS) = 4.
Request a demo
Let us give you a tour around our solution.
Fill in your credentials, and a member of the Cercare Medical team will contact you with a date and time proposal that fits your schedule.
TRY US!
Seamless Upload & Analysis
Upload your medical images securely for state of the art analysis. Discover how Cercare Medical Neurosuite can enhance your perfusion imaging post-processing.